ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1330

The Efficacy of a Multidisciplinary Intervention Strategy for the Treatment of Benign Joint Hypermobility Syndrome (BJHS) in Childhood: A Randomized, Single Center Parallel Group Trial

Peter Bale1, Vicky Easton2, Holly Bacon2, Emma Jerman3, Kate Armon4 and Alex J Macgregor1,5, 1School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, United Kingdom, 2Paediatric Physiotherapy Department, Norfolk and Norwich University Hospital, Norwich, United Kingdom, 3Occupational Therapist, Norwich, United Kingdom, 4Paediatric Rheumatology, Jenny Lind Children's Hospital, Norfolk and Norwich University Hospital, Norwich, United Kingdom, 5Rheumatology, Norfolk and Norwich University Hospital, Norwich, United Kingdom

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: hypermobility, Intervention, pain, pediatric rheumatology and physical therapy

  • Tweet
  • Email
  • Print
Session Information

Title: Pediatric Rheumatology – Clinical and Therapeutic Aspects (ARHP): Pediatrics

Session Type: Abstract Submissions (ARHP)

Background/Purpose: Joint hypermobility is common in childhood and can be associated with musculoskeletal pain and dysfunction.  Current management is delivered by a multidisciplinary team but evidence of efficacy is limited.  This clinical trial aimed to determine whether a structured multidisciplinary intervention resulted in improved clinical outcomes compared with standard care.

Methods: A prospective randomised, single centre parallel group trial comparing an 8-week individualised multidisciplinary intervention programme with current standard management (advice and a physiotherapy appointment).  Children and young people (CYP) were assessed for pain, function, coordination and strength at baseline, 3 and 12 months.

Results: 119 CYP, aged 5 to 16 years, with symptomatic hypermobility were randomised to receive targeted multidisciplinary intervention (I) (n=59) or standard management (S) (n=60).  Of these, 105 were followed to 12-months.  There was a significant improvement in child and parent reported pain, coordination and strength.  However, no added benefit could be shown from the intervention (Table 1).  The number of CYP showing significant pain reduction (>=40%) was 27 (50.0%) (I) vs 21 (41.1%) (S).  Those pain free at 12 months were 29 (56.9%) (I) vs 20 (45.5%) (S).  The response was independent of the degree of hypermobility.

Conclusion:

This is the first RCT to compare a structured multidisciplinary intervention with standard care in symptomatic childhood hypermobility. The study demonstrates significant improvement among subjects but no additional benefit from targeted intervention. The findings emphasise the benefit of information and physiotherapy, but highlight the difficulty in demonstrating subtle benefit from specific interventions without better tools for case definition and outcomes assessment.

 

Baseline score (SD)

Rate of change over 12   months (95% CI)

Outcome variable

Intervention group

Control group

Child pain assessment (Wong-Baker Faces pain scale), (0-5, zero   is the best) n=103. 

2.31 (1.55)

-1.42

(-1.78 to -1.06)

-1.31

(-1.75 to -0.85)

Parent observed pain assessment (0-100 VAS, zero is the best) n=105

35.90 (26.46)

-6.09

(12.90 to 0.73)

-6.22

(-13.62 to 1.18)

Child health assessment questionnaire (CHAQ) (0-3, zero is the best) n=104

0.82 (0.63)

+0.02

(-0.12 to 0.16)

-0.03

(-0.13 to 0.64)

Child health 9 dimensional utility (CHU9D) (0-1, zero is the worst) n=104

0.85 (0.11)

+0.02

(-0.01 to 0.04)

+0.002

(-0.02 to 0.03)

Movement assessment battery for children (M-ABC) (0-100, zero is the worst) n =104

34.56 (28.61)

+2.60

(-2.92 to 8.11)

+8.51

(3.17 to 13.86)

Grip Strength (Dynamometer) n= 104

57.29 (28.30)

+4.55

(0.16 to 8.94)

+6.75

(2.85 to 10.66)

Table 1.  The rate of change in primary and secondary outcomes over 12 month follow-up period, this data includes analysis from multilevel modelling.


Disclosure:

P. Bale,
None;

V. Easton,
None;

H. Bacon,
None;

E. Jerman,
None;

K. Armon,
None;

A. J. Macgregor,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-efficacy-of-a-multidisciplinary-intervention-strategy-for-the-treatment-of-benign-joint-hypermobility-syndrome-bjhs-in-childhood-a-randomized-single-center-parallel-group-trial/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology